Update on glioma biotechnology

•The future of brain tumor treatment necessitates development of innovative approaches.•Areas of progress include immunotherapy, precision medicine and other novel technologies.•Collaboration between cancer specialists, biotechnology industry leaders and investors is key. Neuro-oncological research...

Full description

Saved in:
Bibliographic Details
Published in:Clinical neurology and neurosurgery 2020-08, Vol.195, p.106075-106075, Article 106075
Main Authors: Abrams, Madeline, Reichman, Noah, Khatri, Deepak, Patel, Nitesh V., D’Amico, Randy S., Wong, Tamika, Fralin, Sherese, Li, Mona, Symons, Marc, Langer, David, Filippi, Christopher G., Boockvar, John A.
Format: Article
Language:English
Subjects:
Antibodies
Biotechnology
Biotechnology industry
Brain cancer
Brain research
Brain tumor
Brain tumors
Chemotherapy
Clinical trials
Collaboration
Dendritic cells
Drug delivery
Gene expression
Glioblastoma
Glioma
Immunotherapy
Industry
Kinases
Lymphocytes
Medical prognosis
Medical research
Neurology
Neurosurgery
Pharmaceutical industry
Precision medicine
Tumor necrosis factor-TNF
Tumors
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•The future of brain tumor treatment necessitates development of innovative approaches.•Areas of progress include immunotherapy, precision medicine and other novel technologies.•Collaboration between cancer specialists, biotechnology industry leaders and investors is key. Neuro-oncological research is at the forefront of the rising cancer therapy market, as evidenced by its growing revenue and the multitude of clinical trials investigating innovative treatment approaches. The Feinstein Institute for Medical Research, in conjunction with the Department of Neurosurgery at Lenox Hill Hospital and the Zucker School of Medicine at Hofstra / Northwell, sponsored The Brain Tumor Biotech Summit in New York City in June 2019. The aim of the Summit was to provide a forum that encourages collaboration between cancer specialists, biotechnology and pharmaceutical industry leaders, and the investment community in order to promote innovation and advance emerging therapies for brain tumors. Areas highlighted during the Summit included immunotherapy, precision medicine, and novel applications and experimental treatments such as receptor targeting, methods for improved drug delivery, and innovative intraoperative techniques and technologies. This review synthesizes the recent breakthroughs in brain tumor research as presented at The Brain Tumor Biotech Summit.
ISSN:0303-8467
1872-6968
DOI:10.1016/j.clineuro.2020.106075